Frequency Therapeutics Inc (FREQ)
Delisted
3 Nov 2023
NASDAQ (CM) NASDAQ (CM) Primary $
14. 98
+0.84
+5.9406%
$
- Market Cap
- P/E Ratio
- Div Yield
309,164 Volume
- Eps
$ 14.14
Previous Close Investors:
Day Range
0.28 0.32
Year Range
0.18 5.59
Want to track FREQ and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
NIKKI's Efficacy in Overcoming Lyme Disease to be Presented at 2024 Leap into Health Conference
VANCOUVER, BC / ACCESSWIRE / December 13, 2024 / Frequency Exchange Corp. ("Frequency Exchange" or the "Company") (TSXV:FREQ)(OTC PINK:FRECF), a company focused on the global commercialization of its proprietary "NIKKI" Wearable Wellness Technology, is pleased to announce Founder & CEO Stephen Davis will be presenting at the 2024 Quantum Leap Into Health Conference alongside Dr. Keith Pyne, DC, about NIKKI's efficacy in overcoming Lyme Disease. Dr Pyne's Story: Overcoming Lyme Disease with NIKKI Wellness Technology Dr. Keith Pyne, DC is a renowned medical advisor to professional sports organizations including the MLB, NBA, NHL and NFL, as well as Olympic and collegiate athletic teams.
Accesswire | 1 year ago
